Consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) for GHCL grew by 57% year-on-year to Rs 259 crore from the corresponding period last year's Rs 165 crore.

Shares of Maze Therapeutics rose nearly 1% in their Nasdaq debut on Friday, valuing the kidney disease drug developer at $690.37 million.

“The Fed’s prognosis is for a slower pace of monetary easing moving forward, as the economy is doing well and prices are only slowly returning to target in an environment of great uncertainty,” said ...

The latest inflation figures arrive as President Donald Trump has threatened to impose big import taxes on goods from Canada ...

"Just a dreary day to close out the week" is unfolding Friday across the Lehigh Valley region ahead of a seasonably chilly ...

Apple and other big U.S. companies reporting fatter profits than expected are helping Wall Street shave off more of its sharp ...

Former CEO Pat Gelsinger was ousted last month, well before the completion of his four-year plan to turn around the company ...

U.S. prices increased in December while consumer spending surged, suggesting that the Federal Reserve could delay cutting ...

The Chiefs have pulled off a trick play in each of their Super Bowl wins. What do Andy Reid and company have up their sleeves ...

RTX Corporation reported strong Q4 results with double-digit sales growth across all channels. Read why I have upgraded RTX ...